Add your Comment
Introduction: Dr. Kassouf
- Initiation of the webinar via Zoom
- Introduction of panelists
- Acknowledgement of Save Your Skin, Quebec Lung Association and Quebec Cancer Coalition.
- Present outline: presentation by Dr. Aleksi Suo, testimony by Mr. Chris Isfeld, live Q&A period
Part 1: Dr. Aleksi Suo
- Could you briefly outline the management of melanoma before the COVID-19 pandemic?
- Diagnostic and staging methods: imaging, biomarkers testing, laboratory investigations, hospital visits. The goal here would be to highlight points of contact with the healthcare system.
- Mention the multiple therapeutic modalities: surgery, targeted therapy, chemotherapy, immunotherapy, clinical studies.
- How has the pandemic impacted the management of melanoma?
- The balance between treatment benefits against the risk of exposure and immunosuppression linked to certain treatments.
- What are the benefits of the therapies?
- Which treatments are done for each stage?
- What is done in a medical emergency? Which treatments are prioritized?
- What are the risks associated with treatment?
- Risks depending on the type of treatment.
- What are the risks linked to exposure for each treatment? Frequency of hospital visits?
- Visits for injections, laboratory investigations, routine imaging?
- What are the benefits of the therapies?
- Are patients with cancer at risk for increased complications with COVID-19?
- Do melanoma patients represent a subgroup with a different risk?
- Practically, how does this impact our melanoma patients?
- Are we seeing postponement of treatments? Do postponed treatment have an impact on survival?
- How are urgent cases dealt with? How do you define urgency?
- Do we sometimes see substitutions in treatment with a more acceptable side effect profile? If so, do they have similar benefits?
- How do you manage side effects remotely while ensuring patient compliance?
- Are treatments for clinical trials still underway?
- Finally, how do you make the decision to start or continue treatment?
- Overall, do you notice a gradual recovery in activities in your respective field?
- Are resources readily available? (medical staff, hospital beds. etc.)
- How does the situation at your practicing centre compare to others in the province, nationally, or internationally?
- Any anecdotes, relevant cases you would like to share?
- The balance between treatment benefits against the risk of exposure and immunosuppression linked to certain treatments.
- How can patients continue to protect themselves and reduce the risk of transmission of the COVID-19 infection in healthcare settings and while interacting with healthcare professionals?
- Comment on the measures already in place: telemedicine, PPE, screening methods when visiting hospitals
Part 2: Mr. Chris Isfeld
- Do you feel like you are safe when receiving care?
- Discussion over postponement of treatment and follow-up
- Comment on your communication with healthcare workers
- What are your biggest fears?
- What activities have you adopted to deal with the current situation?
- In terms of infection prevention
- In terms of managing anxiety and stress
- What steps should healthcare professionals take to ensure and maintain your confidence in these uncertain times?
- Any anecdotes you would like to share?
Part 3: Live Question and Answer Period
Evaluation form and acknowledgements
SEE ALL
YOU